What Dolfin (Acetaminophen,Caffeine) treats: Main Uses and Benefits

Dolfin (Acetaminophen, Caffeine) is commonly used to help manage symptoms related to physical discomfort and systemic imbalance. Its primary therapeutic role is applied across domains where additional symptomatic support is needed, and is considered relevant in situations where additional management of discomfort is required. The combination is used across therapeutic domains involving certain distressing symptoms, including common tension-type headaches, migraine manifestations, muscular aches, toothache, backache, and menstrual cramps (dysmenorrhoea).

Dolfin is applied in addressing symptom clusters of mild-to-moderate somatic pain and helps to reduce fever associated with the common cold or flu.

“This preparation supports the patient during difficult episodes by helping to ease the overall symptom burden.”

This provides supportive relief when symptoms interfere with routine activities, contributing to general well-being during symptomatic phases.

---

Quick Fact: Relief for Acute Discomfort
Primary Context	Acute and episodic pain and fever
Key Symptom Axes	Head pain, somatic pain, elevated temperature
Core Benefit	Supportive symptomatic management

Regulatory References

1. Public Assessment Report from the UK's Medicines and Healthcare products Regulatory Agency (MHRA)

Who can and cannot use Dolfin (Acetaminophen,Caffeine)?

Dolfin is typically used by adults and adolescents for the temporary relief of mild to moderate pain, such as tension headaches, migraines, and muscle aches. It is important to follow the directions provided by a healthcare professional or those on the product label.

---

Contraindications and Precautions

Certain individuals should avoid using Dolfin due to the risk of serious side effects or interactions. Contraindications include:

• A known allergy or hypersensitivity to Acetaminophen, Caffeine, or any other ingredient in the product.
• Individuals with severe liver disease or active liver failure, as Acetaminophen can cause hepatotoxicity.
• Individuals taking other medications containing Acetaminophen to avoid accidental overdose.
• Children under a specified age (often 12 or 16, depending on the specific formulation and national guidelines).

Condition
Severe liver impairment
Hypersensitivity to components
Concurrent use with other Acetaminophen products

---

Special consideration is needed for those with underlying conditions like stomach ulcers, gastritis, heart rhythm disorders (due to Caffeine), or those who are pregnant or breastfeeding. A healthcare provider must be consulted before use in these populations to weigh the benefits against potential risks.

Interactions with other medicines and products

Interactions with Dolfin (Acetaminophen, Caffeine) are primarily driven by the risks associated with the acetaminophen component, though the caffeine component also contributes to pharmacodynamic effects.

Contraindicated and High-Risk Combinations

The most critical restriction is the co-administration of Dolfin with any other product containing acetaminophen. This combination is strictly forbidden due to the severe, potentially fatal risk of liver damage (hepatotoxicity).

Pharmacodynamic and Exposure Modification

Interacting Product Category	Effect and Constraint	Regulatory Context
Oral Anticoagulants (e.g., Warfarin)	Acetaminophen may potentiate the anticoagulant effect, increasing the risk of bleeding. Requires close monitoring of International Normalized Ratio (INR), especially with prolonged use.	Clinically Significant
Hepatic Enzyme Inducers (e.g., Phenytoin, Carbamazepine)	These drugs accelerate the metabolism of acetaminophen, leading to increased formation of its toxic metabolite. Increases the risk of hepatotoxicity.	Use with Caution
Cholestyramine	This bile acid sequestrant reduces the absorption of acetaminophen from the gut. Requires time separation (administer acetaminophen at least one hour before or several hours after Cholestyramine).	Pharmacokinetic
Alcohol/Ethanol	Consumption of three or more alcoholic drinks per day significantly increases the risk of severe liver damage when using acetaminophen. Must be strictly limited or avoided.	Safety Precaution

Additive Effects

The caffeine component of Dolfin is a central nervous system (CNS) stimulant. Co-ingestion with large amounts of other caffeine sources (like coffee, tea, or energy drinks) should be avoided to manage potential additive stimulant side effects such as nervousness or irritability.

Acetaminophen exerts its primary activity within the central nervous system (CNS). Its mechanism involves the inhibition of central cyclooxygenase (COX) activity, preferentially targeting COX-2, leading to a diminished synthesis of central prostaglandins, which are key modulators of thermoregulation and nociception. Additionally, an acetaminophen metabolite, AM404, may interact with the endocannabinoid system via transient receptor potential vanilloid 1 (TRPV1) receptor activation and potentially inhibit the reuptake of the endogenous cannabinoid anandamide, modulating descending pain pathways.

Caffeine, a methylxanthine, acts as a non-selective antagonist at adenosine receptors (A1, A2A, A2B, and A3), particularly within the CNS. The blockade of A2A receptors prevents adenosine from inhibiting neurotransmitter release, resulting in increased neuronal firing and subsequent central nervous system stimulation. This central action may contribute to a modulatory effect on nociception. Caffeine also accelerates the gastrointestinal absorption rate of acetaminophen, leading to higher peak plasma concentrations of the co-administered compound.

Dolfin, a fixed-dose combination product containing acetaminophen (500 mg) and caffeine (65 mg), is strictly administered via the oral route as a caplet or tablet. The use of this medicine is based on standardized instructions that define the appropriate dose and schedule.

The typical single dose for adults and adolescents 12 years of age and over is two caplets (delivering 1000 mg acetaminophen and 130 mg caffeine). This dose is intended for intermittent use, with subsequent doses administered as needed at an interval of no less than four to six hours. To ensure proper intake, the solid oral form should be taken with a full glass of water. Standard labeling defines administration limits, which restrict maximum intake to six units (3000 mg acetaminophen) in any 24-hour period, though some labels permit up to eight units.

The procedural instruction is to not take more than directed, and use is constrained to a maximum duration for self-treatment: not more than 10 days for pain or 3 days for fever. Furthermore, due to the caffeine component, official instructions advise avoiding the excessive consumption of dietary caffeine sources during administration. Administration to children under 12 years of age is not covered by the standard label and requires specific medical guidance.

Dolfin (Acetaminophen,Caffeine): Recent Clinical Evidence

Overview of Combination Research

Dolfin, a combination product containing acetaminophen (a pain reliever and fever reducer) and caffeine (a central nervous system stimulant), has been the subject of multiple randomized clinical trials and systematic reviews, particularly for the management of acute pain. Research generally investigates whether the addition of caffeine may enhance or speed up the effect of the primary analgesic component.

Efficacy in Acute Pain States

Clinical studies, including Cochrane reviews and meta-analyses, have explored the efficacy of combining acetaminophen and caffeine, typically at doses of 1000 mg and 130 mg, respectively. These studies have primarily focused on common, non-malignant pain states such as headache (tension-type and migraine), dental pain after extraction, and postpartum pain.

Key findings from these investigations suggest that when acetaminophen is combined with 100 mg or more of caffeine, a small but statistically significant increase in the proportion of participants achieving a good level of pain relief (e.g., 50% maximum relief over four to six hours) is observed compared to using acetaminophen alone. This effect appears independent of the specific type of acute pain studied.

Time to Pain Relief

Trials have also examined the onset of analgesic activity. Some evidence indicates that the combination may be associated with a faster onset of pain relief compared to acetaminophen monotherapy, with significant pain reduction sometimes observed as early as 30 minutes following administration.

Safety Profile

The safety profile of the combination is generally consistent with the known profiles of the individual components. Adverse events reported in the trials were typically mild to moderate. Serious adverse events, such as those related to liver toxicity, are rare at therapeutic doses, though the risk of severe liver damage is associated with exceeding the maximum recommended daily limit for acetaminophen, regardless of formulation.

Key Studies & References Acetaminophen, Butalbital, and Caffeine: MedlinePlus Drug Information (for safety context on acetaminophen limits)

Common questions about Dolfin (Acetaminophen,Caffeine) (FAQ)

Q: How much water should I take Dolfin with?

Official instructions for taking solid oral medicines like Dolfin typically recommend swallowing the caplet or tablet with a full glass of water. This is a common regulatory instruction intended to ensure the medicine is fully swallowed and moves properly through the digestive system.

Q: How long should I wait between doses?

According to the official product information, subsequent doses of Dolfin should be taken as needed, but only after an interval of no less than four to six hours has passed since the previous dose. Observing this minimum waiting period helps patients stay within the established daily dosing limits.

Q: Can I take Dolfin if I am on Warfarin?

Individuals taking oral anticoagulants, such as Warfarin, should consult a health professional prior to using Dolfin. Regulatory documents note that the acetaminophen component may increase the risk of bleeding in these patients. Regulatory precautions note that co-administration may involve close monitoring of the International Normalized Ratio (INR), a measure of clotting time, by a healthcare provider.

Q: Does this medicine treat the cause of the pain or just the symptom?

Dolfin is classified as an analgesic and antipyretic combination. Its official indications state that the medicine is for the temporary relief of minor aches, pains, and fever. Therefore, it works to provide symptomatic relief of discomfort and does not treat the underlying cause of the condition.

Q: Can Dolfin make me drowsy or sleepy?

Official product information for Dolfin does not commonly list drowsiness or sleepiness as a side effect. Since the product contains caffeine, a central nervous system stimulant, the common side effects listed are typically those related to stimulation, such as nervousness and insomnia (difficulty sleeping).

Q: What happens if I miss a dose of Dolfin?

General guidance provided in regulatory patient instructions for this type of medication advises that if a dose is missed, patient guidance commonly advises skipping the missed dose. Dosing instructions caution against taking a double dose to compensate for a missed one.

Q: Is it safe to take Dolfin while pregnant?

Use of Dolfin by pregnant or breastfeeding individuals falls under specific regulatory precautions. Official labels advise that a health professional should be consulted before the medicine is used in these populations. This allows a healthcare provider to weigh the individual benefits against potential risks.

How to Store and Dispose of Dolfin (Acetaminophen,Caffeine)

To ensure stability and safety, Dolfin must be stored at room temperature and kept away from excess heat and moisture. The medication should remain in its original container, tightly closed, and the container's safety cap must be locked correctly to be child-resistant.

It is essential to keep Dolfin out of sight and reach of children and pets. Do not store this medication in the bathroom.

For disposal, the recommended method for unused or expired Dolfin is to utilize a drug take-back program. This medication should not be flushed down the toilet. If a take-back program is unavailable, mix the tablets with an undesirable substance, such as coffee grounds or dirt, seal the mixture in a bag, and discard it in the household trash. Always scratch out all personal information from the prescription label before disposing of the empty packaging.